–(BUSINESS WIRE)–Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwid…
Category: Business
Lpath Grants Pfizer Exclusive Option for Worldwide License for AMD Treatment iSONEP
Lpath, Inc. has entered into an agreement providing Pfizer with an exclusive option for a worldwide license to develop and commercialize iSONEP Lpath’s lead monoclonal antibody product candidate, which is being evaluated for the treatment of wet age-…
Research and Markets: Cataract Surgery – Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/4f2453/cataract_surgery) has announced the addition of GlobalData’s new report “Cataract Surgery – Global Pipeline Analysis, Opportunity Assessment and Market For…
Alcon and Novartis Agree to Merger Terms
HUENENBERG, Switzerland–(BUSINESS WIRE)–Alcon, Inc. (NYSE: ACL) announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not…
InSite Vision Names Timothy Ruane Chief Executive Officer
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, has appointed Timothy Ruane as Chief Executive Officer (CEO) and elected Mr. Ruane to its Board of Directors, effective Decem…
Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook Report Available
Research and Markets has announced the addition of GlobalData’s new report “Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook” to their offering. Our report, Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook provid…
Company Profile for Iris Pharma
–(BUSINESS WIRE)–Iris Pharma is an independent Contract Research Organization (CRO), dedicated to preclinical and clinical research in ophthalmology.
Research and Markets: Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of GlobalData’s new report “Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook” to their offering. The report provides key data, information and analysis on the global premium IOLs market.
OptiMedica’s Catalys™ Precision Laser System Study Published in Science Translational Medicine Shows Marked Advancement in Cataract Surgery
SANTA CLARA, Calif.–(BUSINESS WIRE)–OptiMedica’s Catalys Precision Laser System study featured in the peer-reviewed journal Science Translational Medicine. Results show dramatic improvement in the precision of cataract surgery.
Iris Pharma, Winner of the High Performance Prize in the Growth Category
NICE, France–(BUSINESS WIRE)–IRIS PHARMA, WINNER OF THE HIGH PERFORMANCE PRIZE IN THE GROWTH CATEGORY.
Novartis could stick with 77 percent stake in Alcon
Swiss drugmaker Novartis AG has not ruled out sticking with its 77 percent stake in US-listed eyecare group Alcon, Novartis chief executive Joe Jimenez was quoted as saying on Tuesday. “The intention is to have 100 per cent. But Nestle owned 77 per c…
pSivida Corp. to Present at the Maxim Group Growth Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida to present at Maxim Group Growth Conference
Santen Inc. Appoints Associate Director of Strategic Marketing
Santen Inc., a wholly owned subsidiary of Santen Pharmaceuticals, has announced the appointment of Yuan Chang as the Associate Director of Strategic Marketing.
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2010
WORCESTER, Mass.–(BUSINESS WIRE)–RXi Pharmaceuticals Corporation (Nasdaq: RXII) today reported its financial results for the third quarter ended September 30, 2010. RXi Pharmaceuticals is a recognized leader in RNAi-based therapeutic discovery and development with a comprehensive therapeutic platform that includes both…
Ophthalmic Imaging Systems Reports Third Quarter Financial Results
Ophthalmic Imaging Systems, a leading digital imaging, image management, Electronic Medical Records (EMR) and Practice Management (PM) company, today reported financial results for the three and nine months ended September 30, 2010, and provided an u…
Carl Zeiss Meditec Receives FDA Clearance for the IOLMaster 500 Biometer
Carl Zeiss Meditec today announced that the IOLMaster 500, the newest biometer used to calculate all necessary eye measurements for optimal lens selection for cataract surgery procedures, has received marketing clearance from the U.S. Food and Drug A…
IRIDEX Reports Improved Third Quarter 2010 Financial Results
IRIDEX Corporation today reported financial results for the third quarter ended October 2, 2010. Earnings of $0.9 million or $0.09 per diluted share, up from $0.6 million or $0.07 per diluted share reported in the third quarter 2009. Total sales incr…
Bausch + Lomb Surgical Strengthens Management Team with Three New Appointments
Bausch + Lomb, the global eye health company, has appointed three industry veterans to key management roles in its Surgical business. Brad Paddock has been hired as vice president, Sales; Anthony Sine is appointed vice president, Business Development…
pSivida Corp. Reports Results for the First Quarter Ended September 30, 2010
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida reports first quarter fiscal 2011 results
InSite Vision Reports Third Quarter 2010 Financial Results
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Incorporated (OTCBB:INSV) today reported operating and financial results for the quarter ended September 30, 2010. Total revenue for the third quarter of 2010 was $3.2 million with an operating income of …